SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies
- PMID: 20299542
- DOI: 10.1093/protein/gzp094
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies
Abstract
Bispecific antibodies and asymmetric Fc fusion proteins offer opportunities for important advances in therapeutics. Bivalent IgG depends upon in vivo dimerization of its heavy chains, mediated by homodimeric association of its C(H)3 domains. We have developed a heterodimeric Fc platform that supports the design of bispecific and asymmetric fusion proteins by devising strand-exchange engineered domain (SEED) C(H)3 heterodimers. These derivatives of human IgG and IgA C(H)3 domains create complementary human SEED C(H)3 heterodimers that are composed of alternating segments of human IgA and IgG C(H)3 sequences. The resulting pair of SEED C(H)3 domains preferentially associates to form heterodimers when expressed in mammalian cells. SEEDbody (Sb) fusion proteins consist of [IgG1 hinge]-C(H)2-[SEED C(H)3], that may be genetically linked to one or more fusion partners. This investigation reports on the generation of mono-Fab-Sb and Sb-IL2 monocytokine as models. They were expressed at high levels in NS/0 cells, purified on recombinant protein A resin and were well-behaved in solution. When administered intravenously to mice, Sb pharmacokinetics exhibited the long serum half-life extensions typical of comparable Fc-containing immunofusion and IgG1 controls.
Similar articles
-
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.Protein Eng Des Sel. 2011 May;24(5):447-54. doi: 10.1093/protein/gzq123. Protein Eng Des Sel. 2011. PMID: 21498564
-
Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.J Immunol. 2010 Feb 15;184(4):1968-76. doi: 10.4049/jimmunol.0903296. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083659
-
Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.Cell Mol Immunol. 2007 Apr;4(2):147-51. Cell Mol Immunol. 2007. PMID: 17571461
-
Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.Curr Opin Biotechnol. 2009 Dec;20(6):692-9. doi: 10.1016/j.copbio.2009.10.010. Epub 2009 Nov 4. Curr Opin Biotechnol. 2009. PMID: 19889530 Review.
-
Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.Biotechnol J. 2012 Dec;7(12):1444-50. doi: 10.1002/biot.201200250. Epub 2012 Nov 1. Biotechnol J. 2012. PMID: 23125076 Review.
Cited by
-
Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics.MAbs. 2022 Jan-Dec;14(1):2141637. doi: 10.1080/19420862.2022.2141637. MAbs. 2022. PMID: 36343329 Free PMC article.
-
Biology drives the discovery of bispecific antibodies as innovative therapeutics.Antib Ther. 2020 Feb 17;3(1):18-62. doi: 10.1093/abt/tbaa003. eCollection 2020 Jan. Antib Ther. 2020. PMID: 33928225 Free PMC article. Review.
-
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality.Protein Sci. 2024 Nov;33(11):e5176. doi: 10.1002/pro.5176. Protein Sci. 2024. PMID: 39422475 Free PMC article.
-
Dual Function pH Responsive Bispecific Antibodies for Tumor _targeting and Antigen Depletion in Plasma.Front Immunol. 2019 Aug 9;10:1892. doi: 10.3389/fimmu.2019.01892. eCollection 2019. Front Immunol. 2019. PMID: 31447859 Free PMC article.
-
Engineering IgG-Like Bispecific Antibodies-An Overview.Antibodies (Basel). 2018 Aug 1;7(3):28. doi: 10.3390/antib7030028. Antibodies (Basel). 2018. PMID: 31544880 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous